Vitrolife AB Share Price OTC Markets
Equities
VTRLY
US92852Y1010
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.3 USD | +16.16% |
|
-.--% | -.--% |
05-22 | Sweden's Vitrolife Wraps Up Purchase of Software Group eFertility | MT |
05-22 | Vitrolife AB (OM:VITR) acquired Stb Zorg B.V. | CI |
Sales 2024 * | 3.65B 347M 27.38B | Sales 2025 * | 3.97B 378M 29.8B | Capitalization | 23.33B 2.22B 175B |
---|---|---|---|---|---|
Net income 2024 * | 565M 53.77M 4.24B | Net income 2025 * | 675M 64.24M 5.06B | EV / Sales 2024 * | 6.55 x |
Net Debt 2024 * | 587M 55.83M 4.4B | Net cash position 2025 * | 128M 12.16M 959M | EV / Sales 2025 * | 5.84 x |
P/E ratio 2024 * |
41.3
x | P/E ratio 2025 * |
34.6
x | Employees | 1,132 |
Yield 2024 * |
0.69% | Yield 2025 * |
0.8% | Free-Float | 55.35% |
Latest transcript on Vitrolife AB
1 day | +16.16% |
![Extreme 11.45](/images/extremecours_fleche.png)
![Extreme 11.45](/images/extremecours_fleche.png)
![Extreme 11.45](/images/extremecours_fleche.png)
![Extreme 11.45](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Bronwyn Brophy
CEO | Chief Executive Officer | - | 31/07/23 |
Patrik Tolf
DFI | Director of Finance/CFO | 54 | 31/12/21 |
Chairman | 68 | 06/05/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 53 | 01/05/19 | |
Chairman | 68 | 06/05/15 | |
Director/Board Member | 64 | 26/04/18 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.05% | 7.33B | |
+0.66% | 5.35B | |
+32.11% | 5.68B | |
-18.56% | 3.71B | |
+5.52% | 2.49B | |
-64.99% | 2.35B | |
+28.84% | 2.23B | |
-15.91% | 1.61B | |
-12.23% | 1.36B |
- Stock Market
- Equities
- VITR Stock
- VTRLY Stock